Do children with mild asthma need to take inhaled steroids everyday or only as when they need them?

2021 ◽  
Author(s):  
Ian Sinha ◽  
Richard Kirk
Keyword(s):  
2000 ◽  
Vol 15 (4) ◽  
pp. 687-692 ◽  
Author(s):  
A. Corsico ◽  
R. Pellegrino ◽  
M.C. Zoia ◽  
L. Barbano ◽  
V Brusasco ◽  
...  

2005 ◽  
Vol 38 (12) ◽  
pp. 26
Author(s):  
JON O. EBBERT ◽  
ERIC G. TANGALOS
Keyword(s):  

1995 ◽  
Vol 2 (suppl a) ◽  
pp. 19A-23A ◽  
Author(s):  
Michel-Y Rouleau

Among nonsteroidal anti-inflammatory drugs used in the treatment of adult asthma, sodium cromoglycate and nedocromil sodium are the most frequently prescribed. These medications have a similar efficacy profile in asthma although it has been suggested that nedocromil is more powerful than cromoglycate, particularly in its steroid sparing effects. Both drugs have been recommended as alternatives to steroids in the treatment of mild asthma. They are useful in the prevention of bronchospasm induced by exposure to allergens or to a variety of other stimuli. In comparison with theophylline or low dose inhaled steroids, cromoglycate and nedocromil have shown a similar antiasthmatic efficacy, although this is variable among patients.


1994 ◽  
Vol 331 (11) ◽  
pp. 737-739 ◽  
Author(s):  
Jeffrey M. Drazen ◽  
Elliot Israel
Keyword(s):  

2010 ◽  
Vol 77 (6) ◽  
pp. 364-368
Author(s):  
Susan Razavi Abouhassan ◽  
David M. Lang
Keyword(s):  

PEDIATRICS ◽  
1994 ◽  
Vol 94 (2) ◽  
pp. 268-268
Author(s):  
David Stempel

The investigators feel that this study demonstrates that fluticasone has significantly less systemic effect than beclomethasone. This result does agree with several other articles demonstrating fluticasone's limited systemic effect while being topically very potent. The investigators state that beclomethasone had a significant effed on growth rate. They also discuss the limitations of short term growth studies. They question of whether selecting a population of children who warrant therapy with inhaled steroids (the children in this study had mild asthma) might have a different result because the growth suppressive effect of the inhaled steroid might be countered by the growth enhancing impact of improved disease status.


2012 ◽  
Vol 46 (8) ◽  
pp. 16
Author(s):  
M. ALEXANDER OTTO
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document